This test is most useful if any of these apply to you.
Urinary taurine reflects dietary intake and how your kidneys retain or excrete it. Higher excretion has been associated with lower coronary heart disease mortality across populations and with better kidney transplant outcomes. These findings haven't established that raising your urine result improves your health.
For preventive health, this is an exploratory marker. There is no validated urinary target for nutritional adequacy, heart protection, or longevity. Urine amino acid panels have established uses in evaluating certain metabolic disorders, but that doesn't establish the value of a standalone taurine result for routine health screening.
Taurine is a sulfur-containing compound related to amino acids. Your body doesn't use it to build proteins. It can make taurine from methionine and cysteine, and food supplies additional amounts, especially seafood and meat. Your liver also attaches taurine to bile acids, which help you digest and absorb fats.
Your kidneys filter taurine from the blood and reabsorb much of it. How much leaves in urine depends on both supply and kidney handling. In a small human tracer study, most of the injected label was eventually recovered in urine, partly as unchanged taurine and partly as sulfate. This describes the fate of a labeled dose; it doesn't mean that a urine sample measures all the taurine stored in your body.
This test measures taurine in urine using LC-MS. The method separates compounds and detects them using mass-based signals. Your result is reported in mg/g. The report should identify what the gram denominator refers to; the unit alone doesn't specify it.
When the denominator is creatinine, the result expresses taurine relative to a waste product produced largely by muscle. This reduces the effect of urine dilution, but creatinine also varies with muscle mass, diet, and kidney function. A creatinine-adjusted result is different from the total amount excreted over a full day.
The WHO-CARDIAC study examined full-day urine collections from 24 populations in 16 countries. Urinary taurine differed widely between populations, and populations with higher average excretion had lower coronary heart disease death rates.
In the unadjusted analyses, urinary taurine accounted statistically for about 42% of the differences in death rates between male populations and about 55% between female populations. Those figures describe differences between population averages. They aren't reductions in an individual's risk. The association remained after adjustment for cholesterol, body weight, and the urinary sodium-to-potassium ratio.
Fish consumption and other dietary or social differences could help explain the association. The study used an amino acid analyzer and 24-hour excretion measurements, so its values cannot be applied directly to this LC-MS result in mg/g.
Some studies following individuals measured taurine in serum. These describe circulating taurine, a different measurement from urinary excretion.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| Women in the New York University Women's Health Study | Highest versus lowest third of serum taurine | No clear association with coronary heart disease across the full study; about 60% lower odds in the subgroup with high cholesterol |
| Women in the same cohort | Highest versus lowest third of serum taurine | No clear association with stroke across the full study; about half the odds in women who had never smoked |
| Chinese adults with high blood pressure, including 1,391 cancer cases and 1,391 matched controls | Highest versus lowest quarter of serum taurine | About 28% lower odds of developing cancer |
These observational findings don't establish that supplements prevent these diseases. The heart and stroke findings were limited to subgroups, which makes independent confirmation especially important. None validates a urine taurine target.
Among 678 kidney transplant recipients, higher urinary taurine excretion was associated with a lower risk of later transplant failure. Higher excretion also tracked greater animal protein, meat, and fish intake. Researchers used LC-MS/MS on 24-hour urine collections and examined both total excretion and a taurine-to-creatinine ratio. This is relevant urine evidence, though it doesn't establish that a single sample predicts your transplant's future or that changing taurine intake preserves it.
A separate study found lower urinary taurine in injured kidney transplants, with associations involving poorer kidney function, tissue scarring, and subsequent graft loss. Its research measurements haven't established a treatment rule for this assay.
Another small transplant study found a lower taurine signal within poorly functioning kidneys using magnetic resonance measurements. Urinary and serum taurine did not differ significantly between its groups. Tissue findings therefore cannot be treated as equivalent to a urine result.
Research in type 2 diabetes has also examined urinary taurine among many other molecules. In one study of early diabetic kidney disease, taurine was less useful for distinguishing groups than other candidate markers. Its standalone role in detecting early kidney disease remains unproven.
A study of 161 older adults found lower urinary taurine in people with Alzheimer's disease. Researchers also examined a combination of taurine, other urine markers, and age to distinguish people with mild cognitive impairment. Taurine was measured with an assay kit rather than this LC-MS method. The study doesn't validate this test as a dementia screen.
An exploratory study of age-related muscle loss included taurine in a five-molecule urine panel. The combined panel distinguished study groups, while taurine alone did not reliably do so. The urine measurements used assay kits and were not adjusted for creatinine, which further limits comparison with a creatinine-adjusted LC-MS result.
Much of the aging research concerns taurine in blood and tissues. A longitudinal study published in 2025 found that circulating taurine generally increased or remained stable with age across the human cohorts studied, challenging the idea that it consistently falls as you get older. Urinary taurine has not been validated as a measure of biological age.
Urinary taurine can vary substantially within one person. A small 1964 study reported occasional day-to-day differences of up to 80% in full-day excretion among healthy men. That study used an older chemical method, so 80% should not be treated as the expected variability of this LC-MS test or of a creatinine-adjusted sample.
Higher excretion can reflect greater intake, altered kidney handling, or illness. Lower excretion can reflect lower intake or greater conservation. Neither direction has a universal interpretation as better or worse health.
Taurine is best interpreted alongside these tests.
An at-home stool and urine test integrating microbiome balance, pathogens, digestion, permeability, immune activity, gut metabolites, and neurotransmitter patterns to clarify what is driving bloating, food reactions, fatigue, brain fog, and mood shifts.